nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—Methocarbamol—Felbamate—epilepsy syndrome	0.251	1	CrCrCtD
Carvedilol—VEGFA—epilepsy syndrome	0.0989	0.437	CbGaD
Carvedilol—ADRA2A—epilepsy syndrome	0.0663	0.293	CbGaD
Carvedilol—CYP2D6—epilepsy syndrome	0.0355	0.157	CbGaD
Carvedilol—ABCB1—epilepsy syndrome	0.0254	0.112	CbGaD
Carvedilol—CYP2E1—Trimethadione—epilepsy syndrome	0.0131	0.0497	CbGbCtD
Carvedilol—CYP2E1—Felbamate—epilepsy syndrome	0.0131	0.0497	CbGbCtD
Carvedilol—CYP2E1—Clonazepam—epilepsy syndrome	0.0111	0.0423	CbGbCtD
Carvedilol—CYP1A1—Propofol—epilepsy syndrome	0.00956	0.0364	CbGbCtD
Carvedilol—CYP1A1—Phenobarbital—epilepsy syndrome	0.00914	0.0347	CbGbCtD
Carvedilol—CYP2E1—Rufinamide—epilepsy syndrome	0.00906	0.0345	CbGbCtD
Carvedilol—PTGS1—Diazepam—epilepsy syndrome	0.00866	0.0329	CbGbCtD
Carvedilol—ABCB1—Levetiracetam—epilepsy syndrome	0.00777	0.0296	CbGbCtD
Carvedilol—CYP2E1—Propofol—epilepsy syndrome	0.00739	0.0281	CbGbCtD
Carvedilol—CYP2E1—Phenobarbital—epilepsy syndrome	0.00706	0.0268	CbGbCtD
Carvedilol—CYP2E1—Midazolam—epilepsy syndrome	0.00696	0.0265	CbGbCtD
Carvedilol—PTGS1—Valproic Acid—epilepsy syndrome	0.00683	0.026	CbGbCtD
Carvedilol—CYP2C9—Trimethadione—epilepsy syndrome	0.00681	0.0259	CbGbCtD
Carvedilol—CYP2E1—Diazepam—epilepsy syndrome	0.00669	0.0254	CbGbCtD
Carvedilol—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0064	0.0244	CbGbCtD
Carvedilol—ABCB1—Clobazam—epilepsy syndrome	0.00539	0.0205	CbGbCtD
Carvedilol—ABCB1—Lamotrigine—epilepsy syndrome	0.00519	0.0197	CbGbCtD
Carvedilol—CYP1A2—Carbamazepine—epilepsy syndrome	0.00511	0.0194	CbGbCtD
Carvedilol—CYP1A2—Primidone—epilepsy syndrome	0.00477	0.0181	CbGbCtD
Carvedilol—CYP2C9—Carbamazepine—epilepsy syndrome	0.0046	0.0175	CbGbCtD
Carvedilol—ABCB1—Carbamazepine—epilepsy syndrome	0.00447	0.017	CbGbCtD
Carvedilol—CYP2C9—Primidone—epilepsy syndrome	0.0043	0.0163	CbGbCtD
Carvedilol—CYP1A2—Propofol—epilepsy syndrome	0.00427	0.0162	CbGbCtD
Carvedilol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00426	0.0162	CbGbCtD
Carvedilol—CYP2C9—Phenytoin—epilepsy syndrome	0.00413	0.0157	CbGbCtD
Carvedilol—CYP1A2—Phenobarbital—epilepsy syndrome	0.00408	0.0155	CbGbCtD
Carvedilol—ABCB1—Phenytoin—epilepsy syndrome	0.004	0.0152	CbGbCtD
Carvedilol—CYP3A4—Trimethadione—epilepsy syndrome	0.00396	0.0151	CbGbCtD
Carvedilol—CYP3A4—Felbamate—epilepsy syndrome	0.00396	0.0151	CbGbCtD
Carvedilol—CYP1A2—Diazepam—epilepsy syndrome	0.00387	0.0147	CbGbCtD
Carvedilol—CYP2C9—Propofol—epilepsy syndrome	0.00385	0.0146	CbGbCtD
Carvedilol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00372	0.0142	CbGbCtD
Carvedilol—CYP2C9—Phenobarbital—epilepsy syndrome	0.00368	0.014	CbGbCtD
Carvedilol—ABCB1—Phenobarbital—epilepsy syndrome	0.00357	0.0136	CbGbCtD
Carvedilol—ABCB1—Midazolam—epilepsy syndrome	0.00352	0.0134	CbGbCtD
Carvedilol—CYP2D6—Propofol—epilepsy syndrome	0.00352	0.0134	CbGbCtD
Carvedilol—CYP2C9—Diazepam—epilepsy syndrome	0.00349	0.0133	CbGbCtD
Carvedilol—ABCB1—Diazepam—epilepsy syndrome	0.00338	0.0129	CbGbCtD
Carvedilol—CYP3A4—Clonazepam—epilepsy syndrome	0.00337	0.0128	CbGbCtD
Carvedilol—CYP3A4—Clobazam—epilepsy syndrome	0.00323	0.0123	CbGbCtD
Carvedilol—CYP1A2—Valproic Acid—epilepsy syndrome	0.00305	0.0116	CbGbCtD
Carvedilol—CYP2C9—Valproic Acid—epilepsy syndrome	0.00275	0.0105	CbGbCtD
Carvedilol—CYP3A4—Rufinamide—epilepsy syndrome	0.00275	0.0104	CbGbCtD
Carvedilol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00268	0.0102	CbGbCtD
Carvedilol—CYP3A4—Primidone—epilepsy syndrome	0.0025	0.0095	CbGbCtD
Carvedilol—CYP3A4—Phenytoin—epilepsy syndrome	0.0024	0.00912	CbGbCtD
Carvedilol—CYP3A4—Propofol—epilepsy syndrome	0.00224	0.00851	CbGbCtD
Carvedilol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00214	0.00813	CbGbCtD
Carvedilol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00214	0.00813	CbGbCtD
Carvedilol—CYP3A4—Midazolam—epilepsy syndrome	0.00211	0.00802	CbGbCtD
Carvedilol—CYP3A4—Diazepam—epilepsy syndrome	0.00203	0.00771	CbGbCtD
Carvedilol—CYP3A4—Zonisamide—epilepsy syndrome	0.00198	0.00752	CbGbCtD
Carvedilol—CYP3A4—Valproic Acid—epilepsy syndrome	0.0016	0.00608	CbGbCtD
Carvedilol—VCAM1—tongue—epilepsy syndrome	0.00155	0.0409	CbGeAlD
Carvedilol—GJA1—ganglion—epilepsy syndrome	0.00147	0.0386	CbGeAlD
Carvedilol—CYP3A4—Topiramate—epilepsy syndrome	0.00144	0.00548	CbGbCtD
Carvedilol—GJA1—Methazolamide—Acetazolamide—epilepsy syndrome	0.00134	0.558	CbGdCrCtD
Carvedilol—HIF1A—hindbrain—epilepsy syndrome	0.00115	0.0301	CbGeAlD
Carvedilol—GJA1—hindbrain—epilepsy syndrome	0.00111	0.0292	CbGeAlD
Carvedilol—Ranolazine—SCN9A—epilepsy syndrome	0.000771	0.446	CrCbGaD
Carvedilol—HIF1A—brainstem—epilepsy syndrome	0.000657	0.0173	CbGeAlD
Carvedilol—GJA1—brainstem—epilepsy syndrome	0.000637	0.0168	CbGeAlD
Carvedilol—HIF1A—forebrain—epilepsy syndrome	0.000634	0.0167	CbGeAlD
Carvedilol—GJA1—forebrain—epilepsy syndrome	0.000615	0.0162	CbGeAlD
Carvedilol—NPPB—head—epilepsy syndrome	0.000607	0.016	CbGeAlD
Carvedilol—HIF1A—telencephalon—epilepsy syndrome	0.000583	0.0153	CbGeAlD
Carvedilol—NPPB—nervous system—epilepsy syndrome	0.000575	0.0151	CbGeAlD
Carvedilol—GJA1—telencephalon—epilepsy syndrome	0.000565	0.0149	CbGeAlD
Carvedilol—NPPB—central nervous system—epilepsy syndrome	0.000554	0.0146	CbGeAlD
Carvedilol—NDUFC2—forebrain—epilepsy syndrome	0.000535	0.0141	CbGeAlD
Carvedilol—SELE—medulla oblongata—epilepsy syndrome	0.000517	0.0136	CbGeAlD
Carvedilol—NDUFC2—telencephalon—epilepsy syndrome	0.000492	0.0129	CbGeAlD
Carvedilol—VCAM1—medulla oblongata—epilepsy syndrome	0.000476	0.0125	CbGeAlD
Carvedilol—SELE—midbrain—epilepsy syndrome	0.000473	0.0124	CbGeAlD
Carvedilol—SELE—spinal cord—epilepsy syndrome	0.000461	0.0121	CbGeAlD
Carvedilol—HIF1A—medulla oblongata—epilepsy syndrome	0.000458	0.012	CbGeAlD
Carvedilol—VEGFA—telencephalon—epilepsy syndrome	0.000446	0.0117	CbGeAlD
Carvedilol—GJA1—medulla oblongata—epilepsy syndrome	0.000444	0.0117	CbGeAlD
Carvedilol—NPPB—brain—epilepsy syndrome	0.00044	0.0116	CbGeAlD
Carvedilol—VCAM1—midbrain—epilepsy syndrome	0.000435	0.0114	CbGeAlD
Carvedilol—VCAM1—spinal cord—epilepsy syndrome	0.000424	0.0112	CbGeAlD
Carvedilol—HIF1A—midbrain—epilepsy syndrome	0.000418	0.011	CbGeAlD
Carvedilol—SELE—head—epilepsy syndrome	0.00041	0.0108	CbGeAlD
Carvedilol—HIF1A—spinal cord—epilepsy syndrome	0.000408	0.0107	CbGeAlD
Carvedilol—GJA1—midbrain—epilepsy syndrome	0.000406	0.0107	CbGeAlD
Carvedilol—GJA1—spinal cord—epilepsy syndrome	0.000396	0.0104	CbGeAlD
Carvedilol—SELE—nervous system—epilepsy syndrome	0.000389	0.0102	CbGeAlD
Carvedilol—NDUFC2—medulla oblongata—epilepsy syndrome	0.000387	0.0102	CbGeAlD
Carvedilol—VCAM1—head—epilepsy syndrome	0.000377	0.00993	CbGeAlD
Carvedilol—SELE—central nervous system—epilepsy syndrome	0.000374	0.00985	CbGeAlD
Carvedilol—SELE—cerebellum—epilepsy syndrome	0.000366	0.00963	CbGeAlD
Carvedilol—HIF1A—head—epilepsy syndrome	0.000363	0.00955	CbGeAlD
Carvedilol—VCAM1—nervous system—epilepsy syndrome	0.000358	0.00941	CbGeAlD
Carvedilol—NDUFC2—midbrain—epilepsy syndrome	0.000353	0.0093	CbGeAlD
Carvedilol—GJA1—head—epilepsy syndrome	0.000352	0.00926	CbGeAlD
Carvedilol—NDUFC2—spinal cord—epilepsy syndrome	0.000345	0.00907	CbGeAlD
Carvedilol—VCAM1—central nervous system—epilepsy syndrome	0.000344	0.00906	CbGeAlD
Carvedilol—HIF1A—nervous system—epilepsy syndrome	0.000344	0.00905	CbGeAlD
Carvedilol—GJA1—nervous system—epilepsy syndrome	0.000334	0.00878	CbGeAlD
Carvedilol—HIF1A—central nervous system—epilepsy syndrome	0.000331	0.00872	CbGeAlD
Carvedilol—ADRA1A—hindbrain—epilepsy syndrome	0.000329	0.00867	CbGeAlD
Carvedilol—HIF1A—cerebellum—epilepsy syndrome	0.000324	0.00852	CbGeAlD
Carvedilol—GJA1—central nervous system—epilepsy syndrome	0.000321	0.00846	CbGeAlD
Carvedilol—ADRA1D—forebrain—epilepsy syndrome	0.000317	0.00835	CbGeAlD
Carvedilol—GJA1—cerebellum—epilepsy syndrome	0.000314	0.00826	CbGeAlD
Carvedilol—VEGFA—spinal cord—epilepsy syndrome	0.000313	0.00823	CbGeAlD
Carvedilol—PTGS1—ganglion—epilepsy syndrome	0.000311	0.00819	CbGeAlD
Carvedilol—GJA1—Chlorthalidone—Clonazepam—epilepsy syndrome	0.000311	0.13	CbGdCrCtD
Carvedilol—NDUFC2—head—epilepsy syndrome	0.000306	0.00806	CbGeAlD
Carvedilol—SELE—brain—epilepsy syndrome	0.000297	0.00782	CbGeAlD
Carvedilol—ADRA1D—telencephalon—epilepsy syndrome	0.000292	0.00767	CbGeAlD
Carvedilol—NDUFC2—nervous system—epilepsy syndrome	0.00029	0.00764	CbGeAlD
Carvedilol—NDUFC2—central nervous system—epilepsy syndrome	0.00028	0.00736	CbGeAlD
Carvedilol—NDUFC2—cerebellum—epilepsy syndrome	0.000273	0.00719	CbGeAlD
Carvedilol—VCAM1—brain—epilepsy syndrome	0.000273	0.00719	CbGeAlD
Carvedilol—HIF1A—brain—epilepsy syndrome	0.000263	0.00692	CbGeAlD
Carvedilol—GJA1—brain—epilepsy syndrome	0.000255	0.00671	CbGeAlD
Carvedilol—Tamsulosin—HTR7—epilepsy syndrome	0.000252	0.146	CrCbGaD
Carvedilol—VEGFA—cerebellum—epilepsy syndrome	0.000248	0.00653	CbGeAlD
Carvedilol—ADRB1—forebrain—epilepsy syndrome	0.00023	0.00606	CbGeAlD
Carvedilol—GJA1—Phenytoin—Primidone—epilepsy syndrome	0.000223	0.0929	CbGdCrCtD
Carvedilol—GJA1—Phenytoin—Fosphenytoin—epilepsy syndrome	0.000223	0.0929	CbGdCrCtD
Carvedilol—NDUFC2—brain—epilepsy syndrome	0.000222	0.00584	CbGeAlD
Carvedilol—Tamsulosin—ADRA2A—epilepsy syndrome	0.000216	0.125	CrCbGaD
Carvedilol—ADRB1—telencephalon—epilepsy syndrome	0.000212	0.00557	CbGeAlD
Carvedilol—VEGFA—brain—epilepsy syndrome	0.000201	0.0053	CbGeAlD
Carvedilol—CYP2D6—hindbrain—epilepsy syndrome	0.000194	0.0051	CbGeAlD
Carvedilol—ADRA1A—brainstem—epilepsy syndrome	0.000189	0.00497	CbGeAlD
Carvedilol—ADRA1B—head—epilepsy syndrome	0.000186	0.00489	CbGeAlD
Carvedilol—ADRA1A—forebrain—epilepsy syndrome	0.000182	0.00479	CbGeAlD
Carvedilol—ADRA1D—head—epilepsy syndrome	0.000182	0.00478	CbGeAlD
Carvedilol—ADRA1B—nervous system—epilepsy syndrome	0.000176	0.00463	CbGeAlD
Carvedilol—KCNH2—forebrain—epilepsy syndrome	0.000176	0.00463	CbGeAlD
Carvedilol—ADRA1D—nervous system—epilepsy syndrome	0.000172	0.00453	CbGeAlD
Carvedilol—ADRA1B—central nervous system—epilepsy syndrome	0.000169	0.00446	CbGeAlD
Carvedilol—ADRA1A—telencephalon—epilepsy syndrome	0.000167	0.00441	CbGeAlD
Carvedilol—ADRA1D—central nervous system—epilepsy syndrome	0.000166	0.00436	CbGeAlD
Carvedilol—GJA1—Phenytoin—Phenobarbital—epilepsy syndrome	0.000164	0.0685	CbGdCrCtD
Carvedilol—KCNH2—telencephalon—epilepsy syndrome	0.000162	0.00426	CbGeAlD
Carvedilol—ADRA2C—telencephalon—epilepsy syndrome	0.00016	0.0042	CbGeAlD
Carvedilol—GJA1—Phenytoin—Carbamazepine—epilepsy syndrome	0.000141	0.0588	CbGdCrCtD
Carvedilol—ADRA2A—forebrain—epilepsy syndrome	0.000138	0.00364	CbGeAlD
Carvedilol—ADRA1B—brain—epilepsy syndrome	0.000135	0.00354	CbGeAlD
Carvedilol—ADRB1—head—epilepsy syndrome	0.000132	0.00347	CbGeAlD
Carvedilol—ADRA1D—brain—epilepsy syndrome	0.000132	0.00346	CbGeAlD
Carvedilol—PTGS1—forebrain—epilepsy syndrome	0.000131	0.00343	CbGeAlD
Carvedilol—ADRA2A—telencephalon—epilepsy syndrome	0.000127	0.00335	CbGeAlD
Carvedilol—KCNH2—medulla oblongata—epilepsy syndrome	0.000127	0.00334	CbGeAlD
Carvedilol—ADRA2C—medulla oblongata—epilepsy syndrome	0.000125	0.0033	CbGeAlD
Carvedilol—ADRB1—nervous system—epilepsy syndrome	0.000125	0.00329	CbGeAlD
Carvedilol—CYP2E1—telencephalon—epilepsy syndrome	0.000125	0.00328	CbGeAlD
Carvedilol—Ranolazine—CYP2D6—epilepsy syndrome	0.000121	0.0698	CrCbGaD
Carvedilol—ADRB1—central nervous system—epilepsy syndrome	0.00012	0.00317	CbGeAlD
Carvedilol—PTGS1—telencephalon—epilepsy syndrome	0.00012	0.00316	CbGeAlD
Carvedilol—KCNH2—midbrain—epilepsy syndrome	0.000116	0.00306	CbGeAlD
Carvedilol—Tamsulosin—CYP2D6—epilepsy syndrome	0.000116	0.0672	CrCbGaD
Carvedilol—ADRA2C—midbrain—epilepsy syndrome	0.000115	0.00302	CbGeAlD
Carvedilol—KCNH2—spinal cord—epilepsy syndrome	0.000113	0.00298	CbGeAlD
Carvedilol—ADRA2C—spinal cord—epilepsy syndrome	0.000112	0.00294	CbGeAlD
Carvedilol—CYP2D6—brainstem—epilepsy syndrome	0.000111	0.00293	CbGeAlD
Carvedilol—CYP2D6—forebrain—epilepsy syndrome	0.000107	0.00282	CbGeAlD
Carvedilol—ADRA1A—head—epilepsy syndrome	0.000104	0.00274	CbGeAlD
Carvedilol—KCNH2—head—epilepsy syndrome	0.000101	0.00265	CbGeAlD
Carvedilol—ADRA2A—medulla oblongata—epilepsy syndrome	0.0001	0.00263	CbGeAlD
Carvedilol—ADRA2C—head—epilepsy syndrome	9.94e-05	0.00262	CbGeAlD
Carvedilol—ADRA1A—nervous system—epilepsy syndrome	9.89e-05	0.0026	CbGeAlD
Carvedilol—CYP2D6—telencephalon—epilepsy syndrome	9.86e-05	0.0026	CbGeAlD
Carvedilol—CYP2E1—medulla oblongata—epilepsy syndrome	9.79e-05	0.00258	CbGeAlD
Carvedilol—ADRB1—brain—epilepsy syndrome	9.56e-05	0.00252	CbGeAlD
Carvedilol—KCNH2—nervous system—epilepsy syndrome	9.55e-05	0.00251	CbGeAlD
Carvedilol—ADRA1A—central nervous system—epilepsy syndrome	9.52e-05	0.00251	CbGeAlD
Carvedilol—ADRA2C—nervous system—epilepsy syndrome	9.42e-05	0.00248	CbGeAlD
Carvedilol—ADRA1A—cerebellum—epilepsy syndrome	9.3e-05	0.00245	CbGeAlD
Carvedilol—KCNH2—central nervous system—epilepsy syndrome	9.19e-05	0.00242	CbGeAlD
Carvedilol—ADRA2A—midbrain—epilepsy syndrome	9.14e-05	0.00241	CbGeAlD
Carvedilol—ADRA2C—central nervous system—epilepsy syndrome	9.07e-05	0.00239	CbGeAlD
Carvedilol—KCNH2—cerebellum—epilepsy syndrome	8.99e-05	0.00236	CbGeAlD
Carvedilol—ADRA2A—spinal cord—epilepsy syndrome	8.92e-05	0.00235	CbGeAlD
Carvedilol—ADRA2C—cerebellum—epilepsy syndrome	8.87e-05	0.00233	CbGeAlD
Carvedilol—CYP2E1—spinal cord—epilepsy syndrome	8.73e-05	0.0023	CbGeAlD
Carvedilol—CYP1A1—head—epilepsy syndrome	8.51e-05	0.00224	CbGeAlD
Carvedilol—PTGS1—spinal cord—epilepsy syndrome	8.41e-05	0.00221	CbGeAlD
Carvedilol—CYP1A1—nervous system—epilepsy syndrome	8.06e-05	0.00212	CbGeAlD
Carvedilol—ADRA2A—head—epilepsy syndrome	7.93e-05	0.00209	CbGeAlD
Carvedilol—CYP1A1—central nervous system—epilepsy syndrome	7.76e-05	0.00204	CbGeAlD
Carvedilol—CYP2E1—head—epilepsy syndrome	7.76e-05	0.00204	CbGeAlD
Carvedilol—ABCB1—forebrain—epilepsy syndrome	7.72e-05	0.00203	CbGeAlD
Carvedilol—ADRA1A—brain—epilepsy syndrome	7.56e-05	0.00199	CbGeAlD
Carvedilol—ADRA2A—nervous system—epilepsy syndrome	7.52e-05	0.00198	CbGeAlD
Carvedilol—PTGS1—head—epilepsy syndrome	7.47e-05	0.00197	CbGeAlD
Carvedilol—CYP2E1—nervous system—epilepsy syndrome	7.35e-05	0.00194	CbGeAlD
Carvedilol—KCNH2—brain—epilepsy syndrome	7.3e-05	0.00192	CbGeAlD
Carvedilol—ADRA2A—central nervous system—epilepsy syndrome	7.24e-05	0.0019	CbGeAlD
Carvedilol—ADRA2C—brain—epilepsy syndrome	7.2e-05	0.0019	CbGeAlD
Carvedilol—ABCB1—telencephalon—epilepsy syndrome	7.09e-05	0.00187	CbGeAlD
Carvedilol—PTGS1—nervous system—epilepsy syndrome	7.08e-05	0.00186	CbGeAlD
Carvedilol—CYP2E1—central nervous system—epilepsy syndrome	7.08e-05	0.00186	CbGeAlD
Carvedilol—ADRA2A—cerebellum—epilepsy syndrome	7.07e-05	0.00186	CbGeAlD
Carvedilol—CYP2E1—cerebellum—epilepsy syndrome	6.92e-05	0.00182	CbGeAlD
Carvedilol—PTGS1—central nervous system—epilepsy syndrome	6.82e-05	0.0018	CbGeAlD
Carvedilol—Propafenone—CYP2D6—epilepsy syndrome	6.6e-05	0.0382	CrCbGaD
Carvedilol—CYP1A1—brain—epilepsy syndrome	6.16e-05	0.00162	CbGeAlD
Carvedilol—CYP2D6—head—epilepsy syndrome	6.14e-05	0.00162	CbGeAlD
Carvedilol—Propranolol—CYP2C19—epilepsy syndrome	6.1e-05	0.0353	CrCbGaD
Carvedilol—CYP3A4—nervous system—epilepsy syndrome	5.92e-05	0.00156	CbGeAlD
Carvedilol—CYP2D6—nervous system—epilepsy syndrome	5.82e-05	0.00153	CbGeAlD
Carvedilol—ADRA2A—brain—epilepsy syndrome	5.75e-05	0.00151	CbGeAlD
Carvedilol—CYP3A4—central nervous system—epilepsy syndrome	5.7e-05	0.0015	CbGeAlD
Carvedilol—CYP2E1—brain—epilepsy syndrome	5.62e-05	0.00148	CbGeAlD
Carvedilol—CYP2D6—central nervous system—epilepsy syndrome	5.61e-05	0.00148	CbGeAlD
Carvedilol—ABCB1—medulla oblongata—epilepsy syndrome	5.57e-05	0.00147	CbGeAlD
Carvedilol—CYP2D6—cerebellum—epilepsy syndrome	5.48e-05	0.00144	CbGeAlD
Carvedilol—PTGS1—brain—epilepsy syndrome	5.42e-05	0.00143	CbGeAlD
Carvedilol—ABCB1—midbrain—epilepsy syndrome	5.1e-05	0.00134	CbGeAlD
Carvedilol—ABCB1—spinal cord—epilepsy syndrome	4.97e-05	0.00131	CbGeAlD
Carvedilol—Propafenone—ABCB1—epilepsy syndrome	4.72e-05	0.0273	CrCbGaD
Carvedilol—Propranolol—CYP2D6—epilepsy syndrome	4.52e-05	0.0262	CrCbGaD
Carvedilol—CYP2D6—brain—epilepsy syndrome	4.45e-05	0.00117	CbGeAlD
Carvedilol—ABCB1—head—epilepsy syndrome	4.42e-05	0.00116	CbGeAlD
Carvedilol—ABCB1—nervous system—epilepsy syndrome	4.19e-05	0.0011	CbGeAlD
Carvedilol—ABCB1—central nervous system—epilepsy syndrome	4.03e-05	0.00106	CbGeAlD
Carvedilol—ABCB1—cerebellum—epilepsy syndrome	3.94e-05	0.00104	CbGeAlD
Carvedilol—Propranolol—ABCB1—epilepsy syndrome	3.23e-05	0.0187	CrCbGaD
Carvedilol—ABCB1—brain—epilepsy syndrome	3.2e-05	0.000843	CbGeAlD
Carvedilol—Vomiting—Diazepam—epilepsy syndrome	2.34e-05	0.000185	CcSEcCtD
Carvedilol—Anorexia—Valproic Acid—epilepsy syndrome	2.33e-05	0.000185	CcSEcCtD
Carvedilol—Rash—Diazepam—epilepsy syndrome	2.32e-05	0.000184	CcSEcCtD
Carvedilol—Dermatitis—Diazepam—epilepsy syndrome	2.32e-05	0.000183	CcSEcCtD
Carvedilol—Visual impairment—Topiramate—epilepsy syndrome	2.31e-05	0.000183	CcSEcCtD
Carvedilol—Chest pain—Pregabalin—epilepsy syndrome	2.31e-05	0.000183	CcSEcCtD
Carvedilol—Arthralgia—Pregabalin—epilepsy syndrome	2.31e-05	0.000183	CcSEcCtD
Carvedilol—Myalgia—Pregabalin—epilepsy syndrome	2.31e-05	0.000183	CcSEcCtD
Carvedilol—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Carvedilol—Dizziness—Zonisamide—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Carvedilol—Headache—Diazepam—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Carvedilol—Diarrhoea—Clonazepam—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Carvedilol—Anaemia—Gabapentin—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.29e-05	0.000181	CcSEcCtD
Carvedilol—Hypotension—Valproic Acid—epilepsy syndrome	2.29e-05	0.000181	CcSEcCtD
Carvedilol—Asthenia—Carbamazepine—epilepsy syndrome	2.28e-05	0.000181	CcSEcCtD
Carvedilol—Diarrhoea—Phenytoin—epilepsy syndrome	2.28e-05	0.000181	CcSEcCtD
Carvedilol—Discomfort—Pregabalin—epilepsy syndrome	2.28e-05	0.00018	CcSEcCtD
Carvedilol—Nausea—Fosphenytoin—epilepsy syndrome	2.28e-05	0.00018	CcSEcCtD
Carvedilol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.00018	CcSEcCtD
Carvedilol—Erythema multiforme—Topiramate—epilepsy syndrome	2.27e-05	0.00018	CcSEcCtD
Carvedilol—Angioedema—Gabapentin—epilepsy syndrome	2.27e-05	0.00018	CcSEcCtD
Carvedilol—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.27e-05	0.000179	CcSEcCtD
Carvedilol—Vomiting—Felbamate—epilepsy syndrome	2.26e-05	0.000179	CcSEcCtD
Carvedilol—Dry mouth—Pregabalin—epilepsy syndrome	2.26e-05	0.000179	CcSEcCtD
Carvedilol—Pruritus—Carbamazepine—epilepsy syndrome	2.25e-05	0.000178	CcSEcCtD
Carvedilol—Rash—Felbamate—epilepsy syndrome	2.24e-05	0.000178	CcSEcCtD
Carvedilol—Dermatitis—Felbamate—epilepsy syndrome	2.24e-05	0.000178	CcSEcCtD
Carvedilol—Malaise—Gabapentin—epilepsy syndrome	2.24e-05	0.000177	CcSEcCtD
Carvedilol—Tinnitus—Topiramate—epilepsy syndrome	2.24e-05	0.000177	CcSEcCtD
Carvedilol—Vertigo—Gabapentin—epilepsy syndrome	2.23e-05	0.000177	CcSEcCtD
Carvedilol—Headache—Felbamate—epilepsy syndrome	2.23e-05	0.000177	CcSEcCtD
Carvedilol—Confusional state—Pregabalin—epilepsy syndrome	2.23e-05	0.000176	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.23e-05	0.000176	CcSEcCtD
Carvedilol—Syncope—Gabapentin—epilepsy syndrome	2.23e-05	0.000176	CcSEcCtD
Carvedilol—Leukopenia—Gabapentin—epilepsy syndrome	2.22e-05	0.000176	CcSEcCtD
Carvedilol—Dizziness—Clonazepam—epilepsy syndrome	2.22e-05	0.000176	CcSEcCtD
Carvedilol—Nausea—Vigabatrin—epilepsy syndrome	2.22e-05	0.000176	CcSEcCtD
Carvedilol—Vomiting—Zonisamide—epilepsy syndrome	2.22e-05	0.000175	CcSEcCtD
Carvedilol—Insomnia—Valproic Acid—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Carvedilol—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Carvedilol—Oedema—Pregabalin—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Carvedilol—Asthenia—Lamotrigine—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Carvedilol—Dizziness—Phenytoin—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Carvedilol—Rash—Zonisamide—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Carvedilol—Infection—Pregabalin—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Carvedilol—Paraesthesia—Valproic Acid—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Carvedilol—Palpitations—Gabapentin—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Carvedilol—Dermatitis—Zonisamide—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Carvedilol—Dizziness—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000174	CcSEcCtD
Carvedilol—Nausea—Diazepam—epilepsy syndrome	2.19e-05	0.000173	CcSEcCtD
Carvedilol—Loss of consciousness—Gabapentin—epilepsy syndrome	2.18e-05	0.000173	CcSEcCtD
Carvedilol—Headache—Zonisamide—epilepsy syndrome	2.18e-05	0.000173	CcSEcCtD
Carvedilol—Dyspnoea—Valproic Acid—epilepsy syndrome	2.18e-05	0.000173	CcSEcCtD
Carvedilol—Diarrhoea—Carbamazepine—epilepsy syndrome	2.18e-05	0.000172	CcSEcCtD
Carvedilol—Angiopathy—Topiramate—epilepsy syndrome	2.18e-05	0.000172	CcSEcCtD
Carvedilol—Pruritus—Lamotrigine—epilepsy syndrome	2.18e-05	0.000172	CcSEcCtD
Carvedilol—Shock—Pregabalin—epilepsy syndrome	2.18e-05	0.000172	CcSEcCtD
Carvedilol—Somnolence—Valproic Acid—epilepsy syndrome	2.17e-05	0.000172	CcSEcCtD
Carvedilol—Immune system disorder—Topiramate—epilepsy syndrome	2.17e-05	0.000172	CcSEcCtD
Carvedilol—Cough—Gabapentin—epilepsy syndrome	2.17e-05	0.000172	CcSEcCtD
Carvedilol—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.16e-05	0.000171	CcSEcCtD
Carvedilol—Mediastinal disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000171	CcSEcCtD
Carvedilol—Tachycardia—Pregabalin—epilepsy syndrome	2.16e-05	0.000171	CcSEcCtD
Carvedilol—Dyspepsia—Valproic Acid—epilepsy syndrome	2.15e-05	0.00017	CcSEcCtD
Carvedilol—Convulsion—Gabapentin—epilepsy syndrome	2.15e-05	0.00017	CcSEcCtD
Carvedilol—Skin disorder—Pregabalin—epilepsy syndrome	2.15e-05	0.00017	CcSEcCtD
Carvedilol—Hypertension—Gabapentin—epilepsy syndrome	2.14e-05	0.00017	CcSEcCtD
Carvedilol—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.14e-05	0.000169	CcSEcCtD
Carvedilol—Vomiting—Clonazepam—epilepsy syndrome	2.14e-05	0.000169	CcSEcCtD
Carvedilol—Decreased appetite—Valproic Acid—epilepsy syndrome	2.13e-05	0.000168	CcSEcCtD
Carvedilol—Alopecia—Topiramate—epilepsy syndrome	2.12e-05	0.000168	CcSEcCtD
Carvedilol—Vomiting—Phenytoin—epilepsy syndrome	2.12e-05	0.000168	CcSEcCtD
Carvedilol—Rash—Clonazepam—epilepsy syndrome	2.12e-05	0.000168	CcSEcCtD
Carvedilol—Dermatitis—Clonazepam—epilepsy syndrome	2.12e-05	0.000167	CcSEcCtD
Carvedilol—Arthralgia—Gabapentin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Myalgia—Gabapentin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Chest pain—Gabapentin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Nausea—Felbamate—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Vomiting—Oxcarbazepine—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Fatigue—Valproic Acid—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Anorexia—Pregabalin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Dizziness—Carbamazepine—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Diarrhoea—Lamotrigine—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Carvedilol—Headache—Clonazepam—epilepsy syndrome	2.1e-05	0.000167	CcSEcCtD
Carvedilol—Rash—Phenytoin—epilepsy syndrome	2.1e-05	0.000167	CcSEcCtD
Carvedilol—Dermatitis—Phenytoin—epilepsy syndrome	2.1e-05	0.000166	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.1e-05	0.000166	CcSEcCtD
Carvedilol—Rash—Oxcarbazepine—epilepsy syndrome	2.09e-05	0.000166	CcSEcCtD
Carvedilol—Pain—Valproic Acid—epilepsy syndrome	2.09e-05	0.000166	CcSEcCtD
Carvedilol—Constipation—Valproic Acid—epilepsy syndrome	2.09e-05	0.000166	CcSEcCtD
Carvedilol—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.09e-05	0.000165	CcSEcCtD
Carvedilol—Headache—Phenytoin—epilepsy syndrome	2.09e-05	0.000165	CcSEcCtD
Carvedilol—Malnutrition—Topiramate—epilepsy syndrome	2.09e-05	0.000165	CcSEcCtD
Carvedilol—Discomfort—Gabapentin—epilepsy syndrome	2.09e-05	0.000165	CcSEcCtD
Carvedilol—Headache—Oxcarbazepine—epilepsy syndrome	2.08e-05	0.000165	CcSEcCtD
Carvedilol—Nausea—Zonisamide—epilepsy syndrome	2.07e-05	0.000164	CcSEcCtD
Carvedilol—Dry mouth—Gabapentin—epilepsy syndrome	2.07e-05	0.000164	CcSEcCtD
Carvedilol—Hypotension—Pregabalin—epilepsy syndrome	2.07e-05	0.000164	CcSEcCtD
Carvedilol—Flatulence—Topiramate—epilepsy syndrome	2.06e-05	0.000163	CcSEcCtD
Carvedilol—Tension—Topiramate—epilepsy syndrome	2.05e-05	0.000162	CcSEcCtD
Carvedilol—Confusional state—Gabapentin—epilepsy syndrome	2.04e-05	0.000162	CcSEcCtD
Carvedilol—Dizziness—Lamotrigine—epilepsy syndrome	2.04e-05	0.000161	CcSEcCtD
Carvedilol—Nervousness—Topiramate—epilepsy syndrome	2.03e-05	0.000161	CcSEcCtD
Carvedilol—Oedema—Gabapentin—epilepsy syndrome	2.03e-05	0.00016	CcSEcCtD
Carvedilol—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.03e-05	0.00016	CcSEcCtD
Carvedilol—Vomiting—Carbamazepine—epilepsy syndrome	2.02e-05	0.00016	CcSEcCtD
Carvedilol—Back pain—Topiramate—epilepsy syndrome	2.02e-05	0.00016	CcSEcCtD
Carvedilol—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.02e-05	0.00016	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.01e-05	0.000159	CcSEcCtD
Carvedilol—Infection—Gabapentin—epilepsy syndrome	2.01e-05	0.000159	CcSEcCtD
Carvedilol—Muscle spasms—Topiramate—epilepsy syndrome	2.01e-05	0.000159	CcSEcCtD
Carvedilol—Rash—Carbamazepine—epilepsy syndrome	2.01e-05	0.000159	CcSEcCtD
Carvedilol—Dermatitis—Carbamazepine—epilepsy syndrome	2.01e-05	0.000159	CcSEcCtD
Carvedilol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2e-05	0.000158	CcSEcCtD
Carvedilol—Insomnia—Pregabalin—epilepsy syndrome	2e-05	0.000158	CcSEcCtD
Carvedilol—Nausea—Clonazepam—epilepsy syndrome	2e-05	0.000158	CcSEcCtD
Carvedilol—Headache—Carbamazepine—epilepsy syndrome	2e-05	0.000158	CcSEcCtD
Carvedilol—Shock—Gabapentin—epilepsy syndrome	1.99e-05	0.000158	CcSEcCtD
Carvedilol—Paraesthesia—Pregabalin—epilepsy syndrome	1.99e-05	0.000157	CcSEcCtD
Carvedilol—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.99e-05	0.000157	CcSEcCtD
Carvedilol—Nausea—Phenytoin—epilepsy syndrome	1.98e-05	0.000157	CcSEcCtD
Carvedilol—Tachycardia—Gabapentin—epilepsy syndrome	1.98e-05	0.000157	CcSEcCtD
Carvedilol—Dyspnoea—Pregabalin—epilepsy syndrome	1.97e-05	0.000156	CcSEcCtD
Carvedilol—Nausea—Oxcarbazepine—epilepsy syndrome	1.97e-05	0.000156	CcSEcCtD
Carvedilol—Vision blurred—Topiramate—epilepsy syndrome	1.97e-05	0.000156	CcSEcCtD
Carvedilol—Skin disorder—Gabapentin—epilepsy syndrome	1.97e-05	0.000156	CcSEcCtD
Carvedilol—Somnolence—Pregabalin—epilepsy syndrome	1.97e-05	0.000156	CcSEcCtD
Carvedilol—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.96e-05	0.000155	CcSEcCtD
Carvedilol—Vomiting—Lamotrigine—epilepsy syndrome	1.96e-05	0.000155	CcSEcCtD
Carvedilol—Urticaria—Valproic Acid—epilepsy syndrome	1.94e-05	0.000154	CcSEcCtD
Carvedilol—Rash—Lamotrigine—epilepsy syndrome	1.94e-05	0.000154	CcSEcCtD
Carvedilol—Ill-defined disorder—Topiramate—epilepsy syndrome	1.94e-05	0.000154	CcSEcCtD
Carvedilol—Dermatitis—Lamotrigine—epilepsy syndrome	1.94e-05	0.000153	CcSEcCtD
Carvedilol—Body temperature increased—Valproic Acid—epilepsy syndrome	1.93e-05	0.000153	CcSEcCtD
Carvedilol—Abdominal pain—Valproic Acid—epilepsy syndrome	1.93e-05	0.000153	CcSEcCtD
Carvedilol—Anorexia—Gabapentin—epilepsy syndrome	1.93e-05	0.000153	CcSEcCtD
Carvedilol—Anaemia—Topiramate—epilepsy syndrome	1.93e-05	0.000153	CcSEcCtD
Carvedilol—Headache—Lamotrigine—epilepsy syndrome	1.93e-05	0.000153	CcSEcCtD
Carvedilol—Decreased appetite—Pregabalin—epilepsy syndrome	1.92e-05	0.000152	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.91e-05	0.000151	CcSEcCtD
Carvedilol—Fatigue—Pregabalin—epilepsy syndrome	1.91e-05	0.000151	CcSEcCtD
Carvedilol—Hypotension—Gabapentin—epilepsy syndrome	1.89e-05	0.00015	CcSEcCtD
Carvedilol—Nausea—Carbamazepine—epilepsy syndrome	1.89e-05	0.00015	CcSEcCtD
Carvedilol—Constipation—Pregabalin—epilepsy syndrome	1.89e-05	0.00015	CcSEcCtD
Carvedilol—Pain—Pregabalin—epilepsy syndrome	1.89e-05	0.00015	CcSEcCtD
Carvedilol—Malaise—Topiramate—epilepsy syndrome	1.88e-05	0.000149	CcSEcCtD
Carvedilol—Vertigo—Topiramate—epilepsy syndrome	1.88e-05	0.000149	CcSEcCtD
Carvedilol—Syncope—Topiramate—epilepsy syndrome	1.87e-05	0.000148	CcSEcCtD
Carvedilol—Leukopenia—Topiramate—epilepsy syndrome	1.87e-05	0.000148	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.85e-05	0.000146	CcSEcCtD
Carvedilol—Palpitations—Topiramate—epilepsy syndrome	1.85e-05	0.000146	CcSEcCtD
Carvedilol—Loss of consciousness—Topiramate—epilepsy syndrome	1.84e-05	0.000145	CcSEcCtD
Carvedilol—Insomnia—Gabapentin—epilepsy syndrome	1.83e-05	0.000145	CcSEcCtD
Carvedilol—Nausea—Lamotrigine—epilepsy syndrome	1.83e-05	0.000145	CcSEcCtD
Carvedilol—Cough—Topiramate—epilepsy syndrome	1.82e-05	0.000144	CcSEcCtD
Carvedilol—Feeling abnormal—Pregabalin—epilepsy syndrome	1.82e-05	0.000144	CcSEcCtD
Carvedilol—Paraesthesia—Gabapentin—epilepsy syndrome	1.82e-05	0.000144	CcSEcCtD
Carvedilol—Convulsion—Topiramate—epilepsy syndrome	1.81e-05	0.000143	CcSEcCtD
Carvedilol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.81e-05	0.000143	CcSEcCtD
Carvedilol—Dyspnoea—Gabapentin—epilepsy syndrome	1.81e-05	0.000143	CcSEcCtD
Carvedilol—Hypertension—Topiramate—epilepsy syndrome	1.8e-05	0.000143	CcSEcCtD
Carvedilol—Somnolence—Gabapentin—epilepsy syndrome	1.8e-05	0.000143	CcSEcCtD
Carvedilol—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.8e-05	0.000143	CcSEcCtD
Carvedilol—Dyspepsia—Gabapentin—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Carvedilol—Arthralgia—Topiramate—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Carvedilol—Chest pain—Topiramate—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Carvedilol—Myalgia—Topiramate—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.77e-05	0.00014	CcSEcCtD
Carvedilol—Decreased appetite—Gabapentin—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Carvedilol—Discomfort—Topiramate—epilepsy syndrome	1.76e-05	0.000139	CcSEcCtD
Carvedilol—Urticaria—Pregabalin—epilepsy syndrome	1.76e-05	0.000139	CcSEcCtD
Carvedilol—Asthenia—Valproic Acid—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Carvedilol—Fatigue—Gabapentin—epilepsy syndrome	1.75e-05	0.000138	CcSEcCtD
Carvedilol—Body temperature increased—Pregabalin—epilepsy syndrome	1.75e-05	0.000138	CcSEcCtD
Carvedilol—Abdominal pain—Pregabalin—epilepsy syndrome	1.75e-05	0.000138	CcSEcCtD
Carvedilol—Dry mouth—Topiramate—epilepsy syndrome	1.74e-05	0.000138	CcSEcCtD
Carvedilol—Constipation—Gabapentin—epilepsy syndrome	1.73e-05	0.000137	CcSEcCtD
Carvedilol—Pain—Gabapentin—epilepsy syndrome	1.73e-05	0.000137	CcSEcCtD
Carvedilol—Pruritus—Valproic Acid—epilepsy syndrome	1.73e-05	0.000137	CcSEcCtD
Carvedilol—Confusional state—Topiramate—epilepsy syndrome	1.72e-05	0.000136	CcSEcCtD
Carvedilol—Oedema—Topiramate—epilepsy syndrome	1.71e-05	0.000135	CcSEcCtD
Carvedilol—Infection—Topiramate—epilepsy syndrome	1.69e-05	0.000134	CcSEcCtD
Carvedilol—Shock—Topiramate—epilepsy syndrome	1.68e-05	0.000133	CcSEcCtD
Carvedilol—Diarrhoea—Valproic Acid—epilepsy syndrome	1.67e-05	0.000132	CcSEcCtD
Carvedilol—Feeling abnormal—Gabapentin—epilepsy syndrome	1.67e-05	0.000132	CcSEcCtD
Carvedilol—Thrombocytopenia—Topiramate—epilepsy syndrome	1.67e-05	0.000132	CcSEcCtD
Carvedilol—Tachycardia—Topiramate—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Carvedilol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Carvedilol—Skin disorder—Topiramate—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Carvedilol—Hyperhidrosis—Topiramate—epilepsy syndrome	1.65e-05	0.000131	CcSEcCtD
Carvedilol—Hypersensitivity—Pregabalin—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Carvedilol—Anorexia—Topiramate—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Carvedilol—Dizziness—Valproic Acid—epilepsy syndrome	1.62e-05	0.000128	CcSEcCtD
Carvedilol—Urticaria—Gabapentin—epilepsy syndrome	1.61e-05	0.000127	CcSEcCtD
Carvedilol—Abdominal pain—Gabapentin—epilepsy syndrome	1.6e-05	0.000127	CcSEcCtD
Carvedilol—Body temperature increased—Gabapentin—epilepsy syndrome	1.6e-05	0.000127	CcSEcCtD
Carvedilol—Hypotension—Topiramate—epilepsy syndrome	1.59e-05	0.000126	CcSEcCtD
Carvedilol—Asthenia—Pregabalin—epilepsy syndrome	1.59e-05	0.000126	CcSEcCtD
Carvedilol—Pruritus—Pregabalin—epilepsy syndrome	1.56e-05	0.000124	CcSEcCtD
Carvedilol—Vomiting—Valproic Acid—epilepsy syndrome	1.56e-05	0.000123	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.55e-05	0.000123	CcSEcCtD
Carvedilol—Insomnia—Topiramate—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Carvedilol—Rash—Valproic Acid—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Carvedilol—Dermatitis—Valproic Acid—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Carvedilol—Headache—Valproic Acid—epilepsy syndrome	1.53e-05	0.000121	CcSEcCtD
Carvedilol—Paraesthesia—Topiramate—epilepsy syndrome	1.53e-05	0.000121	CcSEcCtD
Carvedilol—Dyspnoea—Topiramate—epilepsy syndrome	1.52e-05	0.00012	CcSEcCtD
Carvedilol—Somnolence—Topiramate—epilepsy syndrome	1.52e-05	0.00012	CcSEcCtD
Carvedilol—Diarrhoea—Pregabalin—epilepsy syndrome	1.51e-05	0.00012	CcSEcCtD
Carvedilol—Dyspepsia—Topiramate—epilepsy syndrome	1.5e-05	0.000119	CcSEcCtD
Carvedilol—Hypersensitivity—Gabapentin—epilepsy syndrome	1.49e-05	0.000118	CcSEcCtD
Carvedilol—Decreased appetite—Topiramate—epilepsy syndrome	1.48e-05	0.000117	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.47e-05	0.000117	CcSEcCtD
Carvedilol—Fatigue—Topiramate—epilepsy syndrome	1.47e-05	0.000116	CcSEcCtD
Carvedilol—Dizziness—Pregabalin—epilepsy syndrome	1.46e-05	0.000116	CcSEcCtD
Carvedilol—Pain—Topiramate—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Carvedilol—Constipation—Topiramate—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Carvedilol—Asthenia—Gabapentin—epilepsy syndrome	1.45e-05	0.000115	CcSEcCtD
Carvedilol—Nausea—Valproic Acid—epilepsy syndrome	1.45e-05	0.000115	CcSEcCtD
Carvedilol—Pruritus—Gabapentin—epilepsy syndrome	1.43e-05	0.000114	CcSEcCtD
Carvedilol—Vomiting—Pregabalin—epilepsy syndrome	1.41e-05	0.000111	CcSEcCtD
Carvedilol—Feeling abnormal—Topiramate—epilepsy syndrome	1.41e-05	0.000111	CcSEcCtD
Carvedilol—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Carvedilol—Rash—Pregabalin—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Carvedilol—Dermatitis—Pregabalin—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Carvedilol—Diarrhoea—Gabapentin—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Carvedilol—Headache—Pregabalin—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Carvedilol—Urticaria—Topiramate—epilepsy syndrome	1.36e-05	0.000107	CcSEcCtD
Carvedilol—Abdominal pain—Topiramate—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Carvedilol—Body temperature increased—Topiramate—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Carvedilol—Dizziness—Gabapentin—epilepsy syndrome	1.34e-05	0.000106	CcSEcCtD
Carvedilol—Nausea—Pregabalin—epilepsy syndrome	1.31e-05	0.000104	CcSEcCtD
Carvedilol—Vomiting—Gabapentin—epilepsy syndrome	1.29e-05	0.000102	CcSEcCtD
Carvedilol—Rash—Gabapentin—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Carvedilol—Dermatitis—Gabapentin—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Carvedilol—Headache—Gabapentin—epilepsy syndrome	1.27e-05	0.000101	CcSEcCtD
Carvedilol—Hypersensitivity—Topiramate—epilepsy syndrome	1.26e-05	9.95e-05	CcSEcCtD
Carvedilol—Asthenia—Topiramate—epilepsy syndrome	1.22e-05	9.69e-05	CcSEcCtD
Carvedilol—Pruritus—Topiramate—epilepsy syndrome	1.21e-05	9.55e-05	CcSEcCtD
Carvedilol—Nausea—Gabapentin—epilepsy syndrome	1.2e-05	9.53e-05	CcSEcCtD
Carvedilol—Diarrhoea—Topiramate—epilepsy syndrome	1.17e-05	9.24e-05	CcSEcCtD
Carvedilol—Dizziness—Topiramate—epilepsy syndrome	1.13e-05	8.93e-05	CcSEcCtD
Carvedilol—Vomiting—Topiramate—epilepsy syndrome	1.08e-05	8.58e-05	CcSEcCtD
Carvedilol—Rash—Topiramate—epilepsy syndrome	1.08e-05	8.51e-05	CcSEcCtD
Carvedilol—Dermatitis—Topiramate—epilepsy syndrome	1.07e-05	8.51e-05	CcSEcCtD
Carvedilol—Headache—Topiramate—epilepsy syndrome	1.07e-05	8.46e-05	CcSEcCtD
Carvedilol—Nausea—Topiramate—epilepsy syndrome	1.01e-05	8.02e-05	CcSEcCtD
Carvedilol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.11e-07	8.88e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.11e-07	8.88e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	8.09e-07	8.86e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	8.09e-07	8.85e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	8.04e-07	8.8e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	8.04e-07	8.8e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SRC—epilepsy syndrome	8.02e-07	8.78e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	8.01e-07	8.77e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	8.01e-07	8.77e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	8e-07	8.76e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8e-07	8.75e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	7.97e-07	8.72e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.96e-07	8.71e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	7.94e-07	8.69e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	7.94e-07	8.69e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.93e-07	8.68e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	7.91e-07	8.66e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	7.91e-07	8.66e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	7.91e-07	8.66e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AGT—epilepsy syndrome	7.9e-07	8.65e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TH—epilepsy syndrome	7.88e-07	8.63e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	7.87e-07	8.61e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.84e-07	8.58e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	7.84e-07	8.58e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	7.83e-07	8.57e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TH—epilepsy syndrome	7.81e-07	8.55e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	7.81e-07	8.54e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GPX1—epilepsy syndrome	7.8e-07	8.54e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—epilepsy syndrome	7.74e-07	8.47e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	7.69e-07	8.42e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.69e-07	8.42e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	7.68e-07	8.41e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	7.67e-07	8.39e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	7.66e-07	8.38e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	7.65e-07	8.37e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	7.51e-07	8.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.51e-07	8.22e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	7.49e-07	8.2e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	7.49e-07	8.2e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	7.48e-07	8.19e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—epilepsy syndrome	7.46e-07	8.17e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—epilepsy syndrome	7.45e-07	8.15e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	7.4e-07	8.09e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	7.39e-07	8.09e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	7.39e-07	8.09e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	7.37e-07	8.06e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	7.33e-07	8.02e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	7.31e-07	8e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AGT—epilepsy syndrome	7.25e-07	7.94e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	7.24e-07	7.92e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	7.23e-07	7.92e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	7.18e-07	7.86e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	7.17e-07	7.85e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.13e-07	7.81e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	7.12e-07	7.79e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	7.11e-07	7.79e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	7.11e-07	7.78e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—epilepsy syndrome	7.11e-07	7.78e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.1e-07	7.77e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	7.08e-07	7.75e-06	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—epilepsy syndrome	7e-07	7.66e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	6.98e-07	7.64e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	6.97e-07	7.62e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	6.96e-07	7.62e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAT—epilepsy syndrome	6.89e-07	7.54e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	6.84e-07	7.49e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AGT—epilepsy syndrome	6.84e-07	7.49e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	6.82e-07	7.47e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	6.78e-07	7.42e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	6.74e-07	7.37e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	6.7e-07	7.33e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—epilepsy syndrome	6.7e-07	7.33e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	6.7e-07	7.33e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TH—epilepsy syndrome	6.68e-07	7.31e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	6.66e-07	7.29e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—POMC—epilepsy syndrome	6.65e-07	7.28e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.61e-07	7.24e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	6.61e-07	7.24e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	6.6e-07	7.23e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	6.59e-07	7.21e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.58e-07	7.2e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	6.57e-07	7.2e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.57e-07	7.19e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	6.57e-07	7.19e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	6.54e-07	7.16e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	6.54e-07	7.16e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	6.53e-07	7.15e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	6.53e-07	7.15e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.52e-07	7.14e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—epilepsy syndrome	6.52e-07	7.13e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.49e-07	7.1e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	6.48e-07	7.09e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	6.47e-07	7.08e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.45e-07	7.06e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.43e-07	7.04e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.41e-07	7.01e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	6.4e-07	7e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	6.34e-07	6.94e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.31e-07	6.91e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.26e-07	6.85e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.23e-07	6.82e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—POMC—epilepsy syndrome	6.11e-07	6.68e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.1e-07	6.68e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.08e-07	6.65e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	6.07e-07	6.64e-06	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	6.07e-07	6.64e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—epilepsy syndrome	6.06e-07	6.63e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	6.05e-07	6.62e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	6.01e-07	6.58e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	6.01e-07	6.58e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	5.98e-07	6.55e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	5.96e-07	6.52e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	5.95e-07	6.52e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	5.94e-07	6.5e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	5.9e-07	6.46e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	5.87e-07	6.42e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	5.85e-07	6.41e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	5.84e-07	6.39e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	5.82e-07	6.37e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.82e-07	6.37e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.78e-07	6.33e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—POMC—epilepsy syndrome	5.76e-07	6.3e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	5.68e-07	6.22e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	5.62e-07	6.15e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.57e-07	6.1e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—epilepsy syndrome	5.57e-07	6.09e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	5.56e-07	6.08e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	5.53e-07	6.05e-06	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.53e-07	6.05e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	5.51e-07	6.03e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	5.51e-07	6.03e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.5e-07	6.02e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.5e-07	6.02e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.48e-07	6e-06	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.48e-07	5.99e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	5.48e-07	5.99e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGT—epilepsy syndrome	5.46e-07	5.98e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	5.44e-07	5.95e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	5.43e-07	5.94e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	5.42e-07	5.94e-06	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.41e-07	5.92e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	5.36e-07	5.86e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—epilepsy syndrome	5.35e-07	5.86e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.35e-07	5.85e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	5.32e-07	5.82e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	5.3e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	5.29e-07	5.79e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	5.27e-07	5.77e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—epilepsy syndrome	5.25e-07	5.74e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	5.24e-07	5.73e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.23e-07	5.72e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	5.2e-07	5.69e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.17e-07	5.66e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.17e-07	5.66e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TH—epilepsy syndrome	5.15e-07	5.64e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.15e-07	5.63e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	5.13e-07	5.61e-06	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.11e-07	5.6e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.1e-07	5.58e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	5.1e-07	5.58e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	5.07e-07	5.55e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	5.06e-07	5.54e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.04e-07	5.52e-06	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.03e-07	5.51e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.02e-07	5.49e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—epilepsy syndrome	5e-07	5.47e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	4.99e-07	5.47e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	4.99e-07	5.46e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—epilepsy syndrome	4.98e-07	5.46e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.97e-07	5.44e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.97e-07	5.44e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	4.92e-07	5.39e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	4.92e-07	5.38e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	4.91e-07	5.38e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.91e-07	5.37e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	4.87e-07	5.33e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	4.84e-07	5.3e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	4.82e-07	5.27e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	4.79e-07	5.24e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	4.77e-07	5.22e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	4.73e-07	5.17e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	4.71e-07	5.16e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.67e-07	5.11e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.65e-07	5.09e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	4.64e-07	5.08e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.6e-07	5.04e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—POMC—epilepsy syndrome	4.6e-07	5.03e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	4.59e-07	5.03e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	4.57e-07	5e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	4.56e-07	4.99e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.54e-07	4.97e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	4.48e-07	4.9e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.47e-07	4.89e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	4.43e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	4.42e-07	4.83e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.36e-07	4.77e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	4.35e-07	4.76e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.33e-07	4.74e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	4.3e-07	4.71e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.3e-07	4.71e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.3e-07	4.71e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.29e-07	4.7e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.27e-07	4.68e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.24e-07	4.64e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	4.23e-07	4.63e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—epilepsy syndrome	4.19e-07	4.59e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	4.19e-07	4.58e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.15e-07	4.55e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.13e-07	4.52e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	4.12e-07	4.51e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.06e-07	4.44e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	4e-07	4.38e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.95e-07	4.32e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.92e-07	4.29e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.89e-07	4.26e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	3.86e-07	4.22e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.84e-07	4.2e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.77e-07	4.13e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.76e-07	4.11e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.67e-07	4.02e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.67e-07	4.01e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.59e-07	3.93e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.49e-07	3.82e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.46e-07	3.78e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.43e-07	3.75e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.37e-07	3.68e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.35e-07	3.66e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.3e-07	3.61e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—epilepsy syndrome	3.28e-07	3.59e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—epilepsy syndrome	3.28e-07	3.58e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	3.25e-07	3.56e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.96e-07	3.24e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.94e-07	3.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.93e-07	3.2e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.9e-07	3.17e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.83e-07	3.1e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.74e-07	3e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	2.7e-07	2.96e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.67e-07	2.92e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.58e-07	2.83e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—epilepsy syndrome	2.45e-07	2.68e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.4e-07	2.63e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—epilepsy syndrome	2.31e-07	2.53e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.26e-07	2.47e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-07	2.44e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.84e-07	2.02e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.74e-07	1.9e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.72e-07	1.88e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.47e-07	1.61e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.14e-07	1.24e-06	CbGpPWpGaD
